13-21502943-T-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The NM_152726.3(MICU2):c.916A>T(p.Lys306*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00437 in 1,610,568 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.0035 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0045 ( 18 hom. )
Consequence
MICU2
NM_152726.3 stop_gained
NM_152726.3 stop_gained
Scores
5
1
1
Clinical Significance
Conservation
PhyloP100: 3.67
Genes affected
MICU2 (HGNC:31830): (mitochondrial calcium uptake 2) Enables protein heterodimerization activity. Involved in calcium import into the mitochondrion and negative regulation of mitochondrial calcium ion concentration. Located in mitochondrial inner membrane and mitochondrial intermembrane space. Part of uniplex complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP6
Variant 13-21502943-T-A is Benign according to our data. Variant chr13-21502943-T-A is described in ClinVar as [Likely_benign]. Clinvar id is 782571.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MICU2 | NM_152726.3 | c.916A>T | p.Lys306* | stop_gained | 9/12 | ENST00000382374.9 | NP_689939.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MICU2 | ENST00000382374.9 | c.916A>T | p.Lys306* | stop_gained | 9/12 | 1 | NM_152726.3 | ENSP00000371811.4 | ||
MICU2 | ENST00000460488.5 | n.156A>T | non_coding_transcript_exon_variant | 1/3 | 3 | |||||
MICU2 | ENST00000479790.2 | n.131A>T | non_coding_transcript_exon_variant | 1/3 | 2 | |||||
MICU2 | ENST00000480341.5 | n.447A>T | non_coding_transcript_exon_variant | 4/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00352 AC: 535AN: 152174Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
535
AN:
152174
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00301 AC: 749AN: 248452Hom.: 2 AF XY: 0.00312 AC XY: 418AN XY: 134084
GnomAD3 exomes
AF:
AC:
749
AN:
248452
Hom.:
AF XY:
AC XY:
418
AN XY:
134084
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00446 AC: 6506AN: 1458276Hom.: 18 Cov.: 31 AF XY: 0.00435 AC XY: 3154AN XY: 725144
GnomAD4 exome
AF:
AC:
6506
AN:
1458276
Hom.:
Cov.:
31
AF XY:
AC XY:
3154
AN XY:
725144
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00351 AC: 535AN: 152292Hom.: 2 Cov.: 32 AF XY: 0.00333 AC XY: 248AN XY: 74468
GnomAD4 genome
AF:
AC:
535
AN:
152292
Hom.:
Cov.:
32
AF XY:
AC XY:
248
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
20
ALSPAC
AF:
AC:
10
ESP6500AA
AF:
AC:
7
ESP6500EA
AF:
AC:
45
ExAC
AF:
AC:
388
Asia WGS
AF:
AC:
2
AN:
3474
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
MICU2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 13, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
Vest4
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: -17
Find out detailed SpliceAI scores and Pangolin per-transcript scores at